根据美国地区法官的判决，吉列德科学公司有权获得在与制药公司美国默克集团的丙型肝炎专利诉讼中所产生的律师费。
Gilead Sciences Inc is entitled to receive the attorney fees it incurred related to hepatitis C patent litigation with drugmaker Merck & Co Inc, a U.S. district judge has ruled.